Rivastigmine for Dementia Associated with Parkinson's Disease

Emre, Murat; Aarsland, Dag; Albanese, Alberto; Jane Byrne, E.; Deuschl, Günther; Paul De Deyn, Peter; Durif, Franck; Kulisevsky, Jaime; van Laar, Teus; Lees, Andrew; Poewe, Werner; Robillard, Alain; Miguel Rosa, Mário; Ch. Wolters, Erik; Quarg, Peter; Tekin, Sibel; Lane, Roger

doi:10.1056/nejmoa041470

Public

Rivastigmine for Dementia Associated with Parkinson's Disease

Published in New England Journal of Medicine • Dec 9, 2004

Authors:

Murat Emre

Dag Aarsland

Alberto Albanese

Abstract

BACKGROUND: Cholinergic deficits are prominent in patients who have dementia associated with Parkinson's disease. We investigated the effects of the dual cholinesterase inhibitor rivastigmine in such patients. METHODS: Patients in whom mild-to-moderate dementia developed at least 2 years after they ...

Subject

Rivastigmine

Medicine

Dementia

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!